18:1 MPB PE
Manufacturer: Sigma Aldrich
CAS Number: 384835-49-8
Synonym(S): 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (sodium salt)
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 25 MG | 870012C-25-MG | In Stock | ₹ 80,601.08 |
870012C - 25 MG
In Stock
Quantity
1
Base Price: ₹ 80,601.08
GST (18%): ₹ 14,508.194
Total Price: ₹ 95,109.274
form
liquid
packaging
pkg of 1 × 2.5 mL (870012C-25mg)pkg of 2 × 4 mL (870012C-200mg)
manufacturer/tradename
Avanti Polar Lipids 870012C
concentration
10 mg/mL (870012C-25mg)25 mg/mL (870012C-200mg)
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(OCCNC(CCCC(C=C1)=CC=C1N(C(C=C2)=O)C2=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI
1S/C55H89N2O11P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36-54(61)65-46-50(68-55(62)37-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-67-69(63,64)66-45-44-56-51(58)35-33-34-48-38-40-49(41-39-48)57-52(59)42-43-53(57)60;/h17-20,38-43,50H,3-16,21-37,44-47H2,1-2H3,(H,56,58)(H,63,64);/q;+1/p-1/b19-17-,20-18-;/t50-;/m1./s1
InChI key
IILKDCDPRGFBSN-VCRVZWGWSA-M
Other Options
| Image | Product Name | Manufacturer | Price Range | |
|---|---|---|---|---|
 | eMolecules Broadpharm / 181 MPB PE / 5mg / 718091960 / BP-28330 / / 384835-49-8 / [null] / 985.294 / C55H89N2O11P | eMolecules | ₹ 43,313.89 | |
 | 18:1 MPB PE | Sigma Aldrich | ₹ 88,591.80 | |
 | 18:1 MPB PE | ChemScene | ₹ 1,09,003.44 | |
 | 384835-49-8 | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-[4-(p-maleimidophenyl)butyramide] (sodium salt) | A2B Chem | ₹ 36,191.88 |
Related Products
Description
- General description: Maleimidophenyl butyramide (MPB) phosphoethanolamine (PE), also known as DPPE-maleimide, contains maleimide, which is a thiol-reactive moiety and a good electrophile. MPB PE is implicated in liposome preparation.[1]
- Application: 18:1 MPB PE has been used in the preparation of nanoparticles.[2] It has also been used in the preparation of interbilayer-crosslinked multilamellar vesicles (ICMVs).[3]
- Packaging: 5 mL Clear Glass Sealed Ampule (870012C-200mg)
SAFETY INFORMATION
Pictograms
Signal Word
Danger
Hazard Statements
Precautionary Statements
P202 - P301 + P312 - P302 + P352 - P304 + P340 + P311 - P305 + P351 + P338 - P308 + P313
Hazard Classifications
Acute Tox. 3 Inhalation - Acute Tox. 4 Oral - Carc. 2 - Eye Irrit. 2 - Repr. 2 - Skin Irrit. 2 - STOT RE 1 Oral - STOT SE 3
Target Organs
Liver,Kidney, Respiratory system
WGK
WGK 3
Compare Similar Items
Show Difference
form: liquid
packaging: pkg of 1 × 2.5 mL (870012C-25mg)pkg of 2 × 4 mL (870012C-200mg)
manufacturer/tradename: Avanti Polar Lipids 870012C
concentration: 10 mg/mL (870012C-25mg)25 mg/mL (870012C-200mg)
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCC(C=C1)=CC=C1N(C(C=C2)=O)C2=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C55H89N2O11P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36-54(61)65-46-50(68-55(62)37-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-67-69(63,64)66-45-44-56-51(58)35-33-34-48-38-40-49(41-39-48)57-52(59)42-43-53(57)60;/h17-20,38-43,50H,3-16,21-37,44-47H2,1-2H3,(H,56,58)(H,63,64);/q;+1/p-1/b19-17-,20-18-;/t50-;/m1./s1
InChI key: IILKDCDPRGFBSN-VCRVZWGWSA-M
form: powder
packaging: pkg of 2 × 100 mg (870012P-200mg)pkg of 1 × 25 mg (870012P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870012P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCC(C=C1)=CC=C1N(C(C=C2)=O)C2=O)=O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[Na+]
InChI: 1S/C55H89N2O11P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-36-54(61)65-46-50(68-55(62)37-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2)47-67-69(63,64)66-45-44-56-51(58)35-33-34-48-38-40-49(41-39-48)57-52(59)42-43-53(57)60;/h17-20,38-43,50H,3-16,21-37,44-47H2,1-2H3,(H,56,58)(H,63,64);/q;+1/p-1/b19-17-,20-18-;/t50-;/m1./s1
InChI key: IILKDCDPRGFBSN-VCRVZWGWSA-M
form: powder
packaging: pkg of 1 × 100 mg (870013P-100mg)pkg of 1 × 25 mg (870013P-25mg)
manufacturer/tradename: Avanti Polar Lipids 870013P
concentration: __
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(OCCNC(CCCC(C=C1)=CC=C1N(C(C=C2)=O)C2=O)=O)=O)(OC(CCCCCCCCCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[Na+]
InChI: 1S/C51H85N2O11P.Na/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-32-50(57)61-42-46(64-51(58)33-28-26-24-22-20-18-16-14-12-10-8-6-4-2)43-63-65(59,60)62-41-40-52-47(54)31-29-30-44-34-36-45(37-35-44)53-48(55)38-39-49(53)56;/h34-39,46H,3-33,40-43H2,1-2H3,(H,52,54)(H,59,60);/q;+1/p-1/t46-;/m1./s1
InChI key: REKODAHLWDSEBQ-FYQWNKFKSA-M
